Skip Nav Destination
Abstract C173: A first-in-human Phase I study of DS-3078a, an oral TORC1/2 inhibitor, in patients with advanced solid tumors: Preliminary results.
Mol Cancer Ther (2013) 12 (11_Supplement): C173.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- E Geuna
- D Roda
- S Rafii
- B Jimenez
- M Capelan
- K Rihawi
- F Montemurro
- T A Yap
- S B Kaye
- J S De Bono
- L R Molife
- U Banerji
British Journal of Cancer (2015) 113 (11): 1541.
- Bristi Basu
- Emma Dean
- Martina Puglisi
- Alastair Greystoke
- Michael Ong
- Wendy Burke
- Maria Cavallin
- Graham Bigley
- Christopher Womack
- Elizabeth A. Harrington
- Stephen Green
- Elisabeth Oelmann
- Johann S. de Bono
- Malcolm Ranson
- Udai Banerji
Clinical Cancer Research (2015) 21 (15): 3412.
RSS Feeds